New immunization initiatives and progress toward the global control of hepatitis B

Current Opinion in Infectious Diseases

Volumn 15, Issue 5, 2002, Pages 465-469

  Kane, Mark A ^a   Brooks, Alan ^a  

^a PATH   (United States)

Author keywords

Hepatitis B; Immunization

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE;

BUDGET; CHILD CARE; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG COST; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INDUSTRIALIZATION; INFECTION CONTROL; LIVER DISEASE; PREVALENCE; PUBLIC HEALTH SERVICE; REVIEW; VIRUS CARRIER; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; HEALTH; IMMUNOLOGY; VACCINATION;

HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; VACCINATION; WORLD HEALTH;

EID: 0036792225     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200210000-00002     Document Type: Review

References (24)

1. Mahoney FJ, Kane MA. Hepatitis B vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccine. 3rd ed. Philadelphia, PA: WB Saunders; 1999. pp. 158-182.
2. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64:51-68.
3. Fenner F, Henderson, DA, Arita I, et al. Smallpox and its eradication. Geneva: World Health Organization; 1988.
4. World Health Organization and UNICEF. State of the world's vaccines and immunization. Geneva: World Health Organization; 1996.
5. UNICEF. Sustainability of achievements: lessons learned from universal childhood immunization. Report of a Steering Committee; 1996.
6. WHO/UNICEF. Global trends in immunization coverage: 2001. Electronically published at Progress Since the World Summit for Children. www.childinfo.org/eddb/immuni/trends/html [2002].
7. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991; 11:84-92.
8. Van Damme P, Kane M, Meheus A, et al. Integration of hepatitis B vaccination into national immunisation programmes. BMJ 1997; 314:1033-1036.
9. Kane MA, Clements CJ, Hu DJ. Health-sector priorities review: hepatitis B. In: Jamison DT, Mosley WH, et al., editors. Disease control priorities in developing countries. New York: Oxford University Press; 1993. pp. 321-350.
10. Beasley RP, Huang L-Y, Lin C, Chien C. Hepatocellular carcinoma and HBV: a prospective study of 22,707 men in Taiwan. Lancet 1981; 2:1129-1133.
11. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988; 61:1942-1956.
12. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 2:1099-1102.
13. Maynard JE, Kane MA, Alter MJ, Halder SC. Control of hepatitis B by immunization: global perspectives. In: Vyas GN, Dienstag JL, Hoofnagle JH, editors. Viral hepatitis and liver disease. New York: Grune & Stratton; 1988. pp. 967-969.
14. Muraskin WA. The war against hepatitis B: a history of the International Task Force on Hepatitis B Immunization. Philadelphia, PA: University of Pennsylvania Press; 1995.
15. World Bank. World development report 1993: investing in health. Washington, DC: Oxford University Press; 1993.
16. Hall AJ, Robertson RL, Crivelli PE, et al. Cost-effectiveness of hepatitis B vaccine in The Gambia, Trans R Soc Trop Med Hyg 1993; 87:333-336.
17. World Health Organisation. Expanded programme on immunization global advisory group. Weekly Epidemiol Record 1992; 3:11-16.
18. Vryheid RE, Kane MA, Muller N, et al. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 2000; 19:1026-1037.
19. GAVl report from Proto-Board Meeting, Seattle, WA; 1999. www.vaccinealliance.org/reference/board_docs.html [2002].
20. GAVl report from First Board Meeting, New York; 1999. www.vaccinealliance.org/reference/board_docs.html [2002].
21. GAVl guidelines on country proposals for support to immunization services, new and under-used vaccines, and injection safety, version 3; Aug 2001. www.vaccinealliance.org/reference/invite.html [2002].
22. GAVl estimated five-year commitment in US$ to 60 countries as of June 2002. www.vaccinealliance.org/reference/awards.html [2002].
23. Vaccine Fund, Major donors. www.vaccinefund.org [2002].
24. GAVl Financing Task Force. Guidelines for preparing a national immunization program financial sustainability plan; May 2002. www.gaviftf.org [2002].